How a New Test Is Transforming Care for Retinoblastoma
November 13, 2024
Jesse Berry, MD, shares how CHLA’s pioneering liquid biopsy is personalizing care for retinoblastoma.
Study will investigate the use of liquid biopsy for diagnosis and determining disease severity.